1,2-Cyclohexanedione
(Synonyms: 1,2-环己二酮) 目录号 : GC39766
1,2-环己二酮（1,2-Cyclohexanedione）是一种有机化合物，是三种同分异构的环己二酮之一。它是一种无色化合物，可溶于多种有机溶剂。由二氧化硒氧化环己酮而得
Cas No.:765-87-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1,2-Cyclohexanedione is an endogenous metabolite.
| Cas No. | 765-87-7 | SDF | |
| 别名 | 1,2-环己二酮 | ||
| Canonical SMILES | O=C1C(CCCC1)=O | ||
| 分子式 | C6H8O2 | 分子量 | 112.13 |
| 溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 8.9182 mL | 44.5911 mL | 89.1822 mL |
| 5 mM | 1.7836 mL | 8.9182 mL | 17.8364 mL |
| 10 mM | 0.8918 mL | 4.4591 mL | 8.9182 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
1,2-Cyclohexanedione modification of arginine residues in egg-white riboflavin-binding protein
Int J Biochem 1988;20(7):707-11.PMID:3181600DOI:10.1016/0020-711x(88)90166-8.
1. Reaction of 1,2-Cyclohexanedione with arginine residues of egg white riboflavin-binding protein results in a loss of the binding activity. 2. In borate buffer pH 8.0, with 0.15 M cyclohexanedione, the inactivation proceeds with a pseudo-first-order rate constant 0.084 hr.-1. 3. At least 65% of lost riboflavin binding capacity can be recovered on 12 hr incubation in 0.5 M hydroxylamine pH 7.0. 4. All 5 arginine residues are modified, 2-3 of them seem to react much easier than others. 5. The correlation between modification of arginines and protein inactivation, as analyzed by kinetic and statistical methods, suggests that one of low-reactivity residues is "essential" for riboflavin binding. 6. In the holoprotein, one arginine residue is almost completely protected from 1,2-Cyclohexanedione modification. 7. Riboflavin does not dissociate from holoprotein, even on prolongated incubation with the reagent. 8. The protected arginine residue seems to be located in the riboflavin binding pocket of protein macromolecule.
Synthesis and characterization of 1,2-Cyclohexanedione bis-benzoyl-hydrazone and its application to the determination of ti in minerals and rocks
Talanta 1986 Mar;33(3):209-14.PMID:18964068DOI:10.1016/0039-9140(86)80053-4.
The synthesis, spectroscopic characteristics and analytical applications of 1,2-cyclo-hexanedione bis-benzoylhydrazone are reported. The reaction of this new compound with titanium(IV) has been studied spectrophotomelrically. An orange 1:2 metal/ligand complex (lambda(max)= 477 nm, = 1.05 x 10(4) l.mole(-1).cm(-1)) is formed at pH 1.75-3.0 in 3:2 v v ethanol-water medium. The method is simple and selective and has been satisfactorily applied to the determination of titanium in bauxite, Portland cement, amphibolites and granites.
Evidence for an essential arginine residue in the active site of Escherichia coli 2-keto-4-hydroxyglutarate aldolase. Modification with 1,2-Cyclohexanedione
J Biol Chem 1985 May 10;260(9):5480-5.PMID:3886656doi
Treatment of homogeneous preparations of Escherichia coli 2-keto-4-hydroxyglutarate aldolase with 1,2-Cyclohexanedione, 2,3-butanedione, phenylglyoxal, or 2,4-pentanedione results in a time- and concentration-dependent loss of enzymatic activity; the kinetics of inactivation are pseudo-first order. Cyclohexanedione is the most effective modifier; a plot of log (1000/t 1/2) versus log [cyclohexanedione] gives a straight line with slope = 1.1, indicating that one molecule of modifier reacts with each active unit of enzyme. The kinetics of inactivation are first order with respect to cyclohexanedione, suggesting that the loss of activity is due to modification of 1 arginine residue/subunit. Controls establish that this inactivation is not due to modifier-induced dissociation or photoinduced structural alteration of the aldolase. The same Km but decreased Vmax values are obtained when partially inactivated enzyme is compared with native. Amino acid analyses of 95% inactivated aldolase show the loss of 1 arginine/subunit with no significant change in other amino acid residues. Considerable protection against inactivation is provided by the substrates 2-keto-4-hydroxyglutarate and pyruvate (75 and 50%, respectively) and to a lesser extent (40 and 35%, respectively) by analogs like 2-keto-4-hydroxybutyrate and 2-keto-3-deoxyarabonate. In contrast, formaldehyde or glycolaldehyde (analogs of glyoxylate) under similar conditions show no protective effect. These results indicate that an arginine residue is required for E. coli 2-keto-4-hydroxyglutarate aldolase activity; it most likely participates in the active site of the enzyme by interacting with the carboxylate anion of the pyruvate-forming moiety of 2-keto-4-hydroxyglutarate.
Cooperative strengthening of an intramolecular O-H...O hydrogen bond by a weak C-H...O counterpart: matrix-isolation infrared spectroscopy and quantum chemical studies on 3-methyl-1,2-cyclohexanedione
J Phys Chem A 2010 Feb 4;114(4):1650-6.PMID:20041727DOI:10.1021/jp907881b.
Matrix-isolation infrared spectra of 1,2-Cyclohexanedione (CD) and 3-methyl-1,2-cyclohexanedione (3-MeCD) were measured in a nitrogen matrix at 8 K. The spectral features reveal that, in the matrix environment, both molecules exist exclusively in the monohydroxy tautomeric form, which is stabilized by an intramolecular O-H...O=C hydrogen bond (HB). The nu(O-H) band of the enol tautomer of 3-MeCD appears at a relatively lower frequency and displays a somewhat broader bandwidth compared to that of CD, and these spectral differences between the two molecules are interpreted as being due to the formation of an interconnected C-H...O HB, where the enolic oxygen is the HB acceptor and one of the C-H covalent bonds of the methyl group is the HB donor. Electronic structure calculations at the B3LYP/6-311++G**, MP2/6-311++G**, and MP2/cc-pVTZ levels predict that this tautomer (enol-2) is approximately 3.5 kcal/mol more stable than a second enolic form (enol-1) where such interconnected H-bonding is absent. Theoretical analysis with a series of molecules having similar functional groups reveals that part of the excess stability (approximately 1 kcal/mol) of enol-2 originates from a cooperative interaction between the interconnected C-H...O and O-H...O HBs. In the IR spectrum, a weak band at 3007 cm(-1) is assigned to nu(C-H) of the methyl C-H bond involved in the H-bonded network. The spectra predicted by both harmonic and anharmonic calculations reveal that this transition is largely blue-shifted compared to the fundamentals of the other two methyl C-H stretching frequencies that are not involved in H-bonding. The conclusions are corroborated further by natural bond orbital (NBO) analysis.
Synthesis of [1-14C]1,2-Cyclohexanedione bis(4-diethylenoxythiosemicarbazone) and preliminary biodistribution studies of this potential antitumor agent
Int J Appl Radiat Isot 1983 Nov;34(11):1501-4.PMID:6642709DOI:10.1016/0020-708x(83)90283-1.
A new compound, [1-14C]1,2-cyclohexanedione-bis(4-diethylenoxythiosemicarbazone) was found to have significant antitumor activity (% T/C = 245) when tested against sarcoma-180 ascites tumor in mice and thus may be a potentially useful drug. The compound can be easily labeled with 14C by employing the straightforward synthetic procedures detailed in this article. Results of the synthesis and purification are presented. Preliminary biodistribution studies of the labeled compound in both normal and tumor bearing mice were performed. The compound, when administered i.p., is rapidly absorbed and localized into most tissues. Urinary and biliary excretion are its major routes of elimination. Based on these studies, continued evaluation is recommended.